Lakefront Biotherapeutics (LKFT) Non-Current Assets (2013 - 2026)
Lakefront Biotherapeutics' Non-Current Assets was $364.91 million in the quarter ended Mar 31, 2026, down 36.9% from $578.11 million a year earlier and down 4.2% from the prior quarter.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Non-Current Assets (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Non-Current Assets at Lakefront Biotherapeutics came in at $369.52 million, down 57.1% from the prior year.
- Non-Current Assets shows a five-year compound annual growth rate of -75.2% (years ended Dec 2020 to Dec 2025).
- In earlier years, Non-Current Assets was $861.83 million in the year ended Dec 31, 2024 (+61.6%), $533.46 million in the year ended Dec 31, 2023 (-99.9%), $524.34 billion in the year ended Dec 31, 2022 (+33.7%) and $392.07 billion in the year ended Dec 31, 2021 (-1.4%).
- The figure for the quarter ended Mar 31, 2026 marks the lowest quarterly Non-Current Assets since the quarter ended Jun 30, 2021.
- Compared with a year earlier, Non-Current Assets has declined for three straight quarters, with an average decline of 9.1% over the last six quarters.
- The best year-over-year quarter for Non-Current Assets over five years was the quarter ended Dec 31, 2024 (growth of 59.5%); the worst was the quarter ended Dec 31, 2023 (a decline of 99.9%).
- Per Business Quant data, LKFT's Non-Current Assets in the three quarters before the quarter ended Mar 31, 2026 was $380.71 million (quarter ended Dec 31, 2025), $409.04 million (quarter ended Sep 30, 2025) and $637.19 million (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Lakefront Biotherapeutics | 2.01 Bn | 2.01 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 357.20 Mn |
| Dec 31, 2025 | 384.21 Mn |
| Sep 30, 2025 | 410.47 Mn |
| Jun 30, 2025 | 15.62 Mn |
| Mar 31, 2025 | 594.87 Mn |
| Dec 31, 2024 | 828.61 Mn |
| Sep 30, 2024 | 684.46 Mn |
| Mar 31, 2024 | 620.58 Mn |
| Dec 31, 2023 | 548.77 Mn |
| Sep 30, 2023 | 523.10 Mn |
| Mar 31, 2023 | 520.02 Mn |
| Dec 31, 2022 | 530.37 Bn |
| Mar 31, 2022 | 390.23 Mn |
| Dec 31, 2021 | 375.20 Bn |
| Jun 30, 2021 | 358.39 Mn |
| Dec 31, 2020 | 428.51 Bn |
| Jun 30, 2020 | 258.19 Mn |
| Mar 31, 2020 | 234.00 Mn |
| Dec 31, 2019 | 227.05 Mn |
| Sep 30, 2019 | 219.66 Mn |
API Access
Lakefront Biotherapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();